Fibroblast growth factor signalling: from development to cancer, Nature Reviews Cancer, vol.351, issue.2, pp.116-129, 2010. ,
DOI : 10.1038/nrc2780
Cell responses to FGFR3 signalling: growth, differentiation and apoptosis, Experimental Cell Research, vol.304, issue.2, pp.417-431, 2005. ,
DOI : 10.1016/j.yexcr.2004.11.012
Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3, Nature Genetics, vol.25, issue.4, pp.390-397, 1996. ,
DOI : 10.1016/0092-8674(91)90034-V
A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors, Human Molecular Genetics, vol.8, issue.1, pp.35-44, 1999. ,
DOI : 10.1093/hmg/8.1.35
FGFR3 Is a Negative Regulator of the Expansion of Pancreatic Epithelial Cells, Diabetes, vol.56, issue.1, pp.96-106, 2007. ,
DOI : 10.2337/db05-1073
FGFR3 contributes to intestinal crypt cell growth arrest, Journal of Cellular Physiology, vol.200, issue.1, pp.261-268, 2008. ,
DOI : 10.1002/jcp.21401
Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas, Nat Genet, vol.23, pp.18-20, 1999. ,
Mutations As a Prognostic Factor in Nonmuscle Invasive Urothelial Bladder Carcinomas, Journal of Clinical Oncology, vol.24, issue.22, pp.3664-3671, 2006. ,
DOI : 10.1200/JCO.2005.05.1771
Real FX: Fibroblast growth factor receptor 3 mutations in epidermal nevi and associated low grade bladder tumors, pp.1664-1666, 2007. ,
Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer, Cancer Res, vol.60, pp.4049-4052, 2000. ,
Fibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration, British Journal of Cancer, vol.13, issue.7 ,
DOI : 10.1677/erc.0.0080161
Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3, Nature Genetics, vol.56, issue.3, pp.260-264, 1997. ,
DOI : 10.1074/jbc.270.51.30643
The essence of senescence, Genes & Development, vol.24, issue.22, pp.2463-2479, 2010. ,
DOI : 10.1101/gad.1971610
Receptor specificity of the fibroblast growth factor family, J Biol Chem, vol.271, pp.15292-15297, 1996. ,
Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene., Proceedings of the National Academy of Sciences, vol.92, issue.8, pp.3576-3580 ,
DOI : 10.1073/pnas.92.8.3576
Overexpression of pRB in Human Pancreatic Carcinoma Cells: Function in Chemotherapy-Induced Apoptosis, JNCI Journal of the National Cancer Institute, vol.94, issue.2, pp.129-142, 2002. ,
DOI : 10.1093/jnci/94.2.129
The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells, Blood, vol.97, issue.8, pp.2413-2419, 2001. ,
DOI : 10.1182/blood.V97.8.2413
Oncogenic properties of the mutated forms of fibroblast growth factor receptor 3b, Carcinogenesis, vol.27, issue.4, pp.740-747, 2006. ,
DOI : 10.1093/carcin/bgi290
Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells, British Journal of Cancer, vol.61, issue.12, pp.2030-2037, 2009. ,
DOI : 10.1038/sj.bjc.6605142
Disruption of Fibroblast Growth Factor Signal Pathway Inhibits the Growth of Synovial Sarcomas: Potential Application of Signal Inhibitors to Molecular Target Therapy, Clinical Cancer Research, vol.11, issue.7, pp.2702-2712, 2005. ,
DOI : 10.1158/1078-0432.CCR-04-2057
Loss of heterozygosity at 4p16.3 and mutation of FGFR3 in transitional cell carcinoma, Oncogene, vol.20, issue.6, pp.686-691, 2001. ,
DOI : 10.1038/sj.onc.1204110
Fibroblast Growth Factor Receptor 3 (FGFR3)???Analyses of the S249C Mutation and Protein Expression in Primary Cervical Carcinomas, Analytical Cellular Pathology, vol.23, issue.2, pp.45-49, 2001. ,
DOI : 10.1155/2001/521873
FGFR3 and p53 protein expressions in patients with pTa and pT1 urothelial bladder cancer, European Journal of Surgical Oncology (EJSO), vol.32, issue.2, pp.231-237, 2006. ,
DOI : 10.1016/j.ejso.2005.11.018
Consistent genomic alterations in carcinoma in situ of the urinary bladder confirm the presence of two major pathways in bladder cancer development ,
Role of FGFR3 in urothelial cell carcinoma: biomarker and potential therapeutic target, World Journal of Urology, vol.11, issue.3, pp.581-593, 2007. ,
DOI : 10.1007/s00345-007-0213-4
Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells, Journal of Cell Science, vol.123, issue.8, pp.1295-1305, 2010. ,
DOI : 10.1242/jcs.061002
URL : https://hal.archives-ouvertes.fr/hal-00481004
E-Cadherin Regulates the Association between ??-Catenin and Actinin-4, Cancer Research, vol.65, issue.19, pp.8836-8845, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-0718
Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion, Biochemical and Biophysical Research Communications, vol.360, issue.1, pp.109-114, 2007. ,
DOI : 10.1016/j.bbrc.2007.06.036
Deregulated FGFR3 mutants in multiple myeloma cell lines with t(4;14): comparative analysis of Y373C, K650E and the novel G384D mutations, Oncogene, vol.20, issue.27, pp.3553-3562, 2001. ,
DOI : 10.1038/sj.onc.1204465
Expression and functional activity of fibroblast growth factors and their receptors in human pancreatic cancer, International Journal of Cancer, vol.64, issue.5, pp.667-675, 1994. ,
DOI : 10.1002/ijc.2910590515
FGFR3 signaling induces a reversible senescence phenotype in chondrocytes similar to oncogene-induced premature senescence, Bone, vol.47, issue.1, pp.102-110, 2010. ,
DOI : 10.1016/j.bone.2010.03.021
Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling, Cell Cycle, vol.9, issue.15, pp.3085-3099, 2010. ,
DOI : 10.4161/cc.9.15.12521
Transcriptional Activation of the p21WAF1,CIP1,SDI1 Gene by Interleukin-6 Type Cytokines: A PREREQUISITE FOR THEIR PRO-DIFFERENTIATING AND ANTI-APOPTOTIC EFFECTS ON HUMAN OSTEOBLASTIC CELLS, Journal of Biological Chemistry, vol.273, issue.33, pp.21137-21144, 1998. ,
DOI : 10.1074/jbc.273.33.21137
In vivo gene transfer targeting in pancreatic adenocarcinoma with cell surface antigens, Molecular Cancer, vol.11, issue.1, p.81, 2012. ,
DOI : 10.1038/sj.mt.6300030
URL : https://hal.archives-ouvertes.fr/inserm-00776648